Western Gold Resources Ltd. Regains Trading Status and Reports First Assay Results from Gold Duke Project

Western Gold Resources Ltd. (ASX: WGR), a small‑cap exploration outfit focused on gold projects in Australia and West Africa, has recently resolved a temporary trading suspension and released preliminary assay data from its flagship Gold Duke drilling program. The two developments underscore the company’s efforts to advance its exploration pipeline while maintaining regulatory compliance.

1. Resumption of Quotation on the ASX

On 17 September 2025, Western Gold Resources announced that it had requested a suspension of its shares from the ASX listing in order to prepare a formal announcement. The suspension, initiated under Listing Rule 17.2, was lifted the following day. A separate notice published on 18 September 2025 confirms that the securities have been reinstated to quotation and will resume trading on the exchange’s electronic platform from 18 September 2025. The ASX compliance letter from Damian Dinelli, Principal Adviser for Listings Compliance, further confirms the company’s adherence to price‑and‑volume requirements during the suspension period.

The reinstatement was mirrored in German financial news, where the instrument was announced as “WIEDERAUFNAHME/RESUMPTION” (resumption) with the trading schedule effective from 18 September 2025. The consistency across multiple jurisdictions indicates that WGR’s shares are now fully available for trading across international markets.

2. First Assay Results from the Gold Duke Project

Western Gold Resources has been drilling its Grade Control and Infill program at the Gold Duke site, a key gold target in Western Australia. The company completed over 16,000 metres of the planned 35,300 metres, representing more than 45 % of the total programme. On 12 September, the company received the first assay results for 20 drilling holes out of an anticipated 1,107. Although the data is still in raw format and unvalidated, the early results are expected to provide a clearer picture of the target’s mineralisation and guide subsequent drilling decisions.

Key highlights from the preliminary data include:

  • Progress on schedule: The drilling programme is advancing in line with the project’s timetable, ensuring that the company can meet its quarterly reporting deadlines.
  • Data volume: 20 holes constitute a small fraction of the overall drill plan, but the information will be critical for refining the geological model and estimating resource grades.
  • Future reporting: Western Gold Resources has indicated that a full compilation and validation of the assay results will be followed by a formal announcement, likely within the next reporting period.

The release of this information comes at a time when the company’s share price, trading at AUD 0.14 as of 16 September 2025, sits at the 52‑week high. The valuation reflects investor optimism around the company’s exploration progress, despite the negative price‑earnings ratio of ‑8.218 and a modest market capitalisation of AUD 25.3 million.

3. Compliance and Investor Communications

In addition to the suspension and assay data, Western Gold Resources has responded to an ASX price and volume query dated 15 September 2025. The company’s submission, directed to the ASX Compliance team, confirms that all trading activity during the suspension period complied with ASX rules and that no anomalous price movements occurred. The company has also issued a formal announcement to shareholders, detailing the status of the Gold Duke programme and the steps being taken to validate assay data.

4. Outlook

Western Gold Resources’ recent developments suggest a strategic focus on consolidating its exploration assets while maintaining strict regulatory adherence. The resumption of trading provides liquidity for investors, and the preliminary assay results will inform future drilling priorities and potential resource estimates. As the company continues to progress toward a comprehensive resource definition, market participants will likely monitor subsequent assay releases and the company’s quarterly financial disclosures closely.

Note: All figures and statements are based on the latest publicly available information as of 18 September 2025.